Mirum Pharma's Phase 2b Study Of Volixibat For Sclerosing Cholangitis Meets End Point, Shares Gain NASDAQ · Markets 19m ago
‘Misplaced euphoria’: Markets are sleepwalking into a recession amid Iran war oil price shock CNBC · Markets 20m ago
‘Misplaced euphoria’: Markets are sleepwalking into a recession amid Iran war oil price shock CNBC · Economy 20m ago
Palantir gets a downgrade and a lower price target from HSBC ahead of first-quarter earnings CNBC · Economy 21m ago
Berkshire shares trade higher as Buffett successor Abel scores good marks at meeting, earnings jump CNBC · Economy 27m ago